Home / Products / API / Details
video
Masitinib Powder

Masitinib Powder

Appearance: White powder
Specification: 99% min
CAS: 790299-79-5
Molecular Formula: C28H30N6OS
Molecular Weight: 498.64
Shelf Life: 2 Years Proper Storage
Stock: Adequate Stock
Certificate: COA,ISO,GMP, HACCP,SGS
Service: OEM Service(Private Package, Capsules)

Add To Inquiry
Product Introduction

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of masitinib powder in China. We warmly welcome yuo to wholesale bulk masitinib powder for sale here from our factory. Quality products and reasonable price are available.

 

Masitinib Drugs

Masitinib powder is commonly known as Ab 1010 or masitinib mesylate. It is a platelet-derived growth factor α/β receptor tyrosine kinase inhibitor that can treat multiple myeloma, gastrointestinal stromal bad cells, and prostate malignancies. Masitinib has a unique mechanism of action. It plays a special role in oncology-it can affect the survival of deficient cell patients and treat gastrointestinal stromal bad cells caused by Ckit mutations. Masitinib can also inhibit inflammation by acting on mast cells and microglia and is effective for symptoms associated with certain inflammatory central nervous system diseases and degeneration of these diseases.

In recent years, molecular target drug therapy has received extensive attention with the rapid development of the field of lousy cell molecular biology. Masitinib, as a molecular target therapeutic drug, has received more and more attention. More and more studies have found that masitinib is the first tyrosine kinase inhibitor based on the structure of imatinib, which can solve the drug resistance of imatinib by replacing pyrimidine with thiazole through the principle of bioelectronic isosteres sex drugs. In addition, the study also found that masitinib has therapeutic effects on COVID-19, mastocytosis, multiple myeloma, amyotrophic lateral sclerosis, and Alzheimer's disease. Xi'an Sonwu provides not only raw materials but also capsules. If you want to find a masitinib manufacturers, Xi'an Sonwu will be a good choice.

Masitinib powder MF

 

Certificate Of Analysis

Test Items

Specification

Results

Appearance

White powder

Conforms

Melting point

90-95°C

Conforms

Density

1.280±0.06g/cm3(Predicted)

Conforms

Assay

≥98%

99.12%

Solubility

Chloroform (Slightly), DichloroChemicalbookmethane (Slightly), DMSO (Slightly), Methanol (Slightly)

Conforms

Residue On Ignition

Not more than 0.1%

Conforms

Compounds

Comply with the standard

Conforms

Related Substance

Comply with the standard

Conforms

Conclusion

This batch is conforms with standard

 

Where To Buy Masitinib

Xi'an Sonwu Biotech Co. ltd. has more than ten years of manufacturer experience. It has extensive and stable cooperation with countries worldwide in America, Asia, Europe, and Oceania. Xi'an Sonwu has always insisted on product quality first. Serving every customer well and satisfying every customer is Xi'an Sonwu's pursuit. Xi'an Sonwu strictly controls every step, from selecting raw materials to pursuing high-quality products from all aspects, such as material selection, manufacturing, sample testing, and personnel professionalism. In addition, Xi'an Sonwu strives to handle every detail to minimize costs and allow customers to get products with high-cost performance. Based on these, customers have given good feedback on the product. So if you need wholesale masitinib, don't hesitate to contact Xi'an Sonwu.

Xi'an Sonwu ultimately makes certain products quality and also offers samples. Here is the quantity.

Masitinib Form

Sample Amount

MOQ

Powder

10g

10g

 

Customers' Good Comment

Xi'an Sonwu1

 

How Does Masitinib Work

Masitinib powder is a selective kinase inhibitor that can inhibit tyrosine kinases by inhibiting the binding of ATP to mutant tyrosine kinase receptors and blocking the phosphorylation of the activation center of tyrosine kinase receptors. Inhibiting tyrosine kinase inhibits harmful cell proliferation, especially for MCTs that have undergone mutations in the c-kit gene. Masitinib can block the activities of C-kit, FDGRR, Lyn, and FGFR3 tyrosine kinases and the FAK cellular pathway by inhibiting the phosphorylation activity of FAK.

When the concentration of Masitinib is ≤500nM, it is an ATP competitive inhibitor, which can effectively inhibit recombinant PDGFR, intracellular kinase Lyn, and FGFR3. Compared with imatinib, it has a much more potent inhibitory effect on degranulation, cytokines, and migration of bone marrow mast cells. Masitinib inhibited SCF-induced cell proliferation in Ba/F3 cells expressing human wild-type KIT. In Ba/F3 cells expressing PDGFR-α, Masitinib inhibits PDGF-BB-stimulated proliferation and PDGFR-α tyrosine phosphorylation. It can hinder KIT tyrosine phosphorylation when it acts on mast cell bad cell lines and BMMC. When it acts on Ba/F3 cells, it can inhibit the V559D mutation and Δ27 mouse mutation caused by KIT. Masitinib inhibits cell proliferation of HMC-1α155 and FMA3 in mast cell bad cell lines. In addition, masitinib has been shown to block the replication of SARS-CoV-2 by inhibiting the main protease 3CLpro, which means that masitinib can inhibit the replication of COVID-19.

Masitinib powder Mechanism of action

 

Masitinib For ALS

The full name of ALS is amyotrophic lateral sclerosis, also known as motor neuron disease. It is the damage to upper motor neurons. It lowers motor neurons, which leads to the gradual weakness and atrophy of the muscles innervated by the medulla, limbs, trunk, chest, and abdomen. Phenomenon. Masitinib has reduced death and motor neuron atrophy in several mice and animal models. By inhibiting the receptor of CSF-1R, it inhibits the proliferation and activation of glial cells. Mounting evidence suggests that "crosstalk" between microglia, mast cells, and astrocytes in ALS patients may damage motor neurons. Masitinib, on the other hand, inhibits a limited number of kinases targeting microglia and mast cells.

In another 48-week trial, 394 adults with amyotrophic lateral sclerosis were treated with masitinib at 3 or 4.5 mg/day or 100 mg/day riluzole. The study randomized these patients to receive masitinib or a placebo to see how effective and safe the drug was in both groups. According to the study protocol, they can do interim analysis once 50% of the study population (191 patients) reaches the 48-week treatment time point. The final test results were based on the modified version of the Amyotrophic Lateral Sclerosis Functional Rating Scale. The results showed that riluzole delayed the choice of ventilator-dependent or tracheostomy therapy, while masitinib at a dose of 4.5 mg/kg significantly slowed the rate of disease progression. This result also means that masitinib can prolong the life of people in the course of ALS.

 

Masitinib Covid

Masitinib is a broad coronavirus 3CL inhibitor that blocks the replication of SARS-CoV-2. In a set of in vivo experiments in mice, the research team intranasally infected 20 K18-hACE2 transgenic mice with 2×10E4 PFU of the new coronavirus. Half were treated with PBS as a control group, and the other half were treated with masitinib (25 mg/kg) twice a day, starting 12 hours post-infection and continuing for ten days. On the sixth day of the experiment, masitinib was able to reduce the new coronavirus's titer in the mice's lungs and nose to less than 1% of the original, and it also can reduce lung inflammation. It can maintain activity in experimental mice, treat their inflammation, and is effective against the new crown's α, β, and γ mutant strains.

The study also showed that masitinib has a strong inhibitory effect on various coronaviruses and human pathogens that can cause multiple diseases, including the common cold, meningitis, hepatitis, and polio. In addition to effectively inhibiting the new coronavirus and its mutant strains, masitinib is also effective against various coronaviruses and small RNA viruses. It can potentially treat other viral infections and be a broad-spectrum antiviral drug.

Masitinib powder COVID-19

 

Factory

1. Xi'an Sonwu Biotech Co., Ltd has a factory with sufficient inventory. Xi'an Sonwu has a clean and well-equipped production department. Under Xi'an Sonwu, researchers constantly develop the best products to meet customers' needs.

2. Xi'an Sonwu Biotech Co., Ltd. has advanced testing equipment and professional testing personnel, all of which show that Xi'an Sonwu is committed to providing accurate and effective data and good services.

factory 1

factory 2

 

Certificate

Xi'an Sonwu4

 

Package

Xi'an Sonwu5

 

Logistics

Xi'an Sonwu2

Besides guaranteeing the product, the other most important thing is customers can receive the goods smoothly. So, Xi'an Sonwu supplies all kinds of couriers according to different needs.

logistics

 

FAQ

Please pay attention when taking masitinib. If there is

Diarrhea

Nausea and vomiting

Rash

Swelling in the lower leg, upper arm, or hand

Low hemoglobin levels

For gastrointestinal disorders, edema, and other symptoms, be sure to get in touch with your doctor as soon as possible. In addition, please note that masitinib can increase the risk of heart disease.

If you want to konw masitinib powder price or have other questions about the product, do not hesitate to contact Xi'an Sonwu.

Email: sales@sonwu.com

Hot Tags: masitinib powder, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, Cabergoline Powder, Orotic Acid Lithium Salt Monohydrate, Coenzyme Urolithin B, Ibrutinib powder, NMN Powder, Indole 3 Carbinol powder

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag